Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema-Reference-Cited by-同舟云学术

Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema

Published:2016-08-30 Issue:6 Volume:47 Page:542-557
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Hiramine Yasunari¹,Uto Hirofumi²³,Imamura Yasushi¹,Hiwaki Takuya¹,Kure Takeshi¹,Ijuin Sho³,Oda Kohei³,Mawatari Seiichi³,Kumagai Kotaro³,Tokunaga Koki³,Higashi Hirofumi⁴,Kanetsuki Ichiro⁵,Kubozono Osamu¹,Maenohara Shigeho⁶,Ido Akio³

Affiliation:

1. Department of Internal Medicine; Kagoshima Kouseiren Hospital; Kagoshima Japan

2. Center for Digestive and Liver Diseases; Miyazaki Medical Center Hospital; Miyazaki Japan

3. Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences; Kagoshima University Graduate School of Medical and Dental Sciences; Kagoshima Japan

4. Department of Hygiene and Public Health, School of Medicine; National Institute of Fitness and Sports in Kanoya; Kagoshima Japan

5. Department of Radiology; Kagoshima Kouseiren Hospital; Kagoshima Japan

6. Department of Surgery; Kagoshima Kouseiren Hospital; Kagoshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12778/fullpdf

Reference58 articles.

1. Furosemide, a blocker of Na+/K+/2Cl− cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 state;Shiozaki;J Physiol Sci,2006

2. Dietary salt intake modulates differential splicing of the Na-K-2Cl cotransporter NKCC2;Schiessl;Am J Physiol Renal Physiol,2013